| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |